Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
3.38
Nov 20 • 3:59 PM ET Dollar change-2.79 Percentage change(-45.22%)
Aftermarket Close
3.11
Aftermarket • 7:30 PM ET Dollar change-0.27 Percentage change(-7.99%)
Today, 6:31 PMNo clear catalyst identified for Zoar 45% drop on third trading day
Index
-
Market Cap
30.24M
Enterprise Value
33.47M
Income
1.61M
Sales
0.04M
Book/sh
1.18
Cash/sh
0.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
8
IPO
Sep 16, 2024
P/E
16.28
Forward P/E
-
PEG
-
P/S
756.12
P/B
2.85
P/C
1512.24
P/FCF
252.04
EV/EBITDA
-
EV/Sales
836.87
Quick Ratio
0.02
Current Ratio
0.04
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
0.21
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
15.09% -48.52%
Sales past 3/5Y
- -
EPS Y/Y TTM
100.44%
Sales Y/Y TTM
52.00%
EPS Q/Q
95.04%
Sales Q/Q
16.67%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
7.36%
Insider Trans
-0.14%
Inst Own
3.58%
Inst Trans
0.29%
ROA
9.32%
ROE
371.29%
ROIC
15.95%
Gross Margin
-4026.32%
Oper. Margin
-12623.68%
Profit Margin
4247.37%
SMA20
-20.09%
SMA50
-29.24%
SMA200
-45.14%
Trades
Shs Outstand
8.54M
Shs Float
7.91M
52W High
10.47 -67.73%
52W Low
2.43 39.09%
Volatility
10.21% 15.39%
ATR (14)
0.80
RSI (14)
42.10
Beta
1.38
Rel Volume
1.25
Avg Volume
17.62K
Volume
21,986
Perf Week
-34.24%
Perf Month
-11.05%
Perf Quarter
-40.88%
Perf Half Y
-50.75%
Perf YTD
-46.96%
Perf Year
-40.48%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
6.17
Price
3.38
Change %
-45.22%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DSS, INC.10% OwnerSep 24 '26Sale7.061561,101589,518Sep 24 07:37 PM
DSS, INC.10% OwnerSep 22 '26Sale0.55723398589,701Sep 24 07:37 PM
DSS, INC.10% OwnerSep 23 '26Sale6.9527188589,674Sep 24 07:37 PM
DSS INC.StockholderApr 22 '26Proposed Sale0.7231,939,77823,064,209Apr 29 06:08 PM
Macko Todd DChief Financial OfficerMar 27 '26Sale0.5643,40024,369155,122Mar 30 09:06 PM
Macko Todd DChief Financial OfficerMar 25 '26Sale0.601,600961198,122Mar 30 09:06 PM
Grady JasonDirectorMar 23 '26Sale0.6550,00032,505250,182Mar 25 07:55 PM
Develops, manufactures and markets API orphan drugs
J.D.Mr. Frank D. Heuszel Esq.
CFOMr. Todd D. Macko C.P.A.
Chief Operating OfficerMr. Mark J. Suseck